Condition
Nasolabial Folds Correction
Total Trials
3
Recruiting
0
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Withdrawn1
Active Not Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT06872359Not ApplicableActive Not Recruiting
Evaluation of Performance and Safety of Injectable KIO017 Device Range for Facial Tissue Filling
NCT03273556Not ApplicableCompletedPrimary
Evaluation of the Filler Performance on the Nasolabial Folds of Aliaxin® EV With and Without Lidocaine 0.3%
NCT02006173Not ApplicableWithdrawnPrimary
Safety and Efficacy Study of Lidocaine Mixed Hyaluronate on Nasolabial Folds Correction
Showing all 3 trials